CACaption Management, LLC
Institutional investor · Portfolio as of Q2 2020
Top Holdings894 positions
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction |
|---|---|---|---|---|---|---|---|
SHOPIFY INC - CLASS A | 204,300 | $193.9M | 6.5% | — | — | — | New — |
VANECK ETF TRUST | 620,000 | $75.6M | 2.5% | — | — | — | New — |
WAYFAIR INC- CLASS A | 263,748 | $52.1M | 1.7% | $120.12 | +66.69% | 2 qtrssince 2020-Q1 | Increased 72 |
Biohaven Ltd. | 494,500 | $36.2M | 1.2% | — | — | — | Increased — |
SUNRUN INC | 1.4M | $28.6M | 1.0% | — | — | — | Increased — |
HILTON WORLDWIDE HLDGS | 381,500 | $28M | 0.9% | — | — | — | New — |
T-MOBILE US INC | 259,800 | $27.1M | 0.9% | — | — | — | Increased — |
ALIBABA GROUP HOLDING-SP ADR | 125,000 | $27M | 0.9% | — | — | — | Increased — |
SIMON PROPERTY GROUP INC | 387,300 | $26.5M | 0.9% | — | — | — | Increased — |
AMGEN INC | 100,000 | $23.6M | 0.8% | — | — | — | New — |
TAL ED GROUP | 330,000 | $22.6M | 0.8% | — | — | — | New — |
WAYFAIR INC- CLASS A | 110,000 | $21.7M | 0.7% | — | — | — | New — |
| 371,300 | $21.4M | 0.7% | — | — | — | Increased — | |
SOLAREDGE TECHNOLOGIES INC | 148,183 | $20.6M | 0.7% | $137.06 | 0.00% | 1 qtr | New 55 |
WIX COM LTD | 78,000 | $20M | 0.7% | — | — | — | Decreased — |
INTRA-CELLULAR THERAPIES INC | 723,600 | $18.6M | 0.6% | — | — | — | Increased — |
STONECO LTD-A | 465,700 | $18.1M | 0.6% | — | — | — | New — |
ENPHASE ENERGY INC | 369,500 | $17.6M | 0.6% | — | — | — | Increased — |
AMERICAN AIRLINES GROUP INC | 1.3M | $17.5M | 0.6% | — | — | — | New — |
AERCAP HOLDINGS NV | 563,000 | $17.3M | 0.6% | — | — | — | New — |
Caption Management, LLC manages $3B across 894 positions as of Q2 2020. Top holdings: SHOP (6.5%), OIH (2.5%), W (1.7%). Fund DNA: Momentum Trader. HoldingsIntel Rating: 1/5.0.
Active quarter - 158 new positions, 167 exits, 56 increased. Top move: W (INCREASED, conviction 72). Portfolio: $3.0B across 894 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer